For filings with the FSA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii
Genesis Emerging Markets Fund Ltd
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already
issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify): X
Correction to TR-1 form submitted on 25/03/2010. There has been no change in control of the voting rights held by
Lazard Asset management LLC, TR-1 was lodged in error due to custodian error.
3. Full name of person(s) subject to the to the notification obligation: iii
Lazard Asset Management LLC
4. Full name of shareholder(s)(if different from 3.):iv
Bank One
JP Morgan Chase Prime
Mellon Trust
Northern Trust Co
PFPC Trust Co
State Street Bank - Custody Master Trust
5. Date of the transaction and date on which the threshold is crossed or reached: v
23/03/10
6. Date on which issuer notified:
26/03/10
7. Threshold(s) that is/are crossed or reached: vi, vii
5%
8. Notified details:
A: Voting rights attached to shares viii, ix
Class/type of shares if possible using the ISIN CODE: GG00B4L0PD47
Situation previous to the triggering transaction
Number of Shares :
Number of Voting Rights : 5,407,924
Resulting situation after the triggering transaction
Number of Shares - Direct:
Number of Voting Rights - Direct xi:
Number of Voting Rights - Indirect xii: 7,267,124
% of Voting Rights x - Direct:
% of Voting Rights x - Indirect: 5.385%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument :
Expiration date xiii:
Exercise/Conversion Period xiv:
Number of voting rights that may be acquired if the instrument is exercised/converted.
% of voting rights:
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi
Resulting situation after the triggering transaction
Type of financial instrument:
Exercise price
Expiration date xvii
Exercise/Conversion period xviii
Number of voting rights instrument refers to
% of voting rights xix,xx
Nominal:
Delta:
Total (A+B+C)
Number of voting rights Percentage of voting rights
7,267,124 Less than 5.385%
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively
held, if applicable: xxi
Lazard Asset Management LLC controls all the voting rights held of this issuer.
Proxy Voting:
10. Name of the proxy holder: N/A
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
14. Contact name: Legal & Compliance Department
15. Contact telephone number: 0207 448 2047
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.